Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maia Zoller
Institutions:
University of Colorado Anschutz,
University of Colorado Denver
Observed institutions:
University of Colorado Anschutz,
University of Colorado Denver
ORCID:
0009-0006-4994-0636
Observed ORCID:
0009-0006-4994-0636
OpenAlex ID:
A5134376850
Table S2 from Inhibiting CXCR2 Remodels the Tumor Microenvironment and Blunts Tumor Progression and Dissemination of High-Grade Serous Carcinoma
2026
·
Railey G. Mikeska
, Lily Elizabeth R. Feldman
, et al.
Data from Inhibiting CXCR2 Remodels the Tumor Microenvironment and Blunts Tumor Progression and Dissemination of High-Grade Serous Carcinoma
2026
·
Railey G. Mikeska
, Lily Elizabeth R. Feldman
, et al.
Table S3 from Inhibiting CXCR2 Remodels the Tumor Microenvironment and Blunts Tumor Progression and Dissemination of High-Grade Serous Carcinoma
2026
·
Railey G. Mikeska
, Lily Elizabeth R. Feldman
, et al.
Table 1 from Inhibiting CXCR2 Remodels the Tumor Microenvironment and Blunts Tumor Progression and Dissemination of High-Grade Serous Carcinoma
2026
·
Railey G. Mikeska
, Lily Elizabeth R. Feldman
, et al.
Figure S1 from Inhibiting CXCR2 Remodels the Tumor Microenvironment and Blunts Tumor Progression and Dissemination of High-Grade Serous Carcinoma
2026
·
Railey G. Mikeska
, Lily Elizabeth R. Feldman
, et al.
Table S4 from Inhibiting CXCR2 Remodels the Tumor Microenvironment and Blunts Tumor Progression and Dissemination of High-Grade Serous Carcinoma
2026
·
Railey G. Mikeska
, Lily Elizabeth R. Feldman
, et al.
Figue S2 from Inhibiting CXCR2 Remodels the Tumor Microenvironment and Blunts Tumor Progression and Dissemination of High-Grade Serous Carcinoma
2026
·
Railey G. Mikeska
, Lily Elizabeth R. Feldman
, et al.
Table S1 from Inhibiting CXCR2 Remodels the Tumor Microenvironment and Blunts Tumor Progression and Dissemination of High-Grade Serous Carcinoma
2026
·
Railey G. Mikeska
, Lily Elizabeth R. Feldman
, et al.
Inhibiting CXCR2 Remodels the Tumor Microenvironment and Blunts Tumor Progression and Dissemination of High-Grade Serous Carcinoma
2026
·
Railey G. Mikeska
, Lily Elizabeth R. Feldman
, et al.
·
Cancer Research Communications
Reversing chemotherapy induced immunosuppression via inhibition of CXCR2
2026
·
Nicole Marjon
, Katharine Linder
, et al.
·
Gynecologic Oncology
Show more works
View as search
Works count:
10
Citation count:
H-index:
I10-index:
Year
Topic
Type